Swiss National Bank Harmony Biosciences Holdings, Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Swiss National Bank holds 61,000 shares of HRMY stock, worth $2.08 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

61,000

Previous 61,500 0.81%

Holding current value

$2.08 Million

Previous $1.86 Million 31.32%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$30.0 - $39.95 $15,000 - $19,975	-500 Reduced 0.81%	61,000 $2.44 Million
Q2 2024 Aug 08, 2024	SELL	$28.81 - $33.01 $60,501 - $69,321	-2,100 Reduced 3.3%	61,500 $1.86 Million
Q1 2024 May 07, 2024	SELL	$29.93 - $35.06 $44,895 - $52,590	-1,500 Reduced 2.3%	63,600 $2.14 Million
Q4 2023 Feb 06, 2024	SELL	$19.2 - $33.78 $268,800 - $472,920	-14,000 Reduced 17.7%	65,100 $2.1 Million
Q3 2023 Nov 08, 2023	BUY	$31.89 - $39.03 $232,797 - $284,919	7,300 Added 10.17%	79,100 $2.59 Million
Q2 2023 Aug 09, 2023	BUY	$30.5 - $37.4 $628,300 - $770,440	20,600 Added 40.23%	71,800 $2.53 Million
Q1 2023 May 10, 2023	SELL	$30.8 - $53.92 $181,720 - $318,128	-5,900 Reduced 10.33%	51,200 $1.67 Million
Q4 2022 Feb 08, 2023	BUY	$45.4 - $60.91 $49,940 - $67,001	1,100 Added 1.96%	57,100 $3.15 Million
Q3 2022 Nov 09, 2022	BUY	$42.06 - $55.45 $37,854 - $49,905	900 Added 1.63%	56,000 $2.48 Million
Q2 2022 Aug 09, 2022	BUY	$33.54 - $52.15 $456,144 - $709,240	13,600 Added 32.77%	55,100 $2.69 Million
Q1 2022 May 09, 2022	BUY	$33.14 - $51.13 $129,246 - $199,407	3,900 Added 10.37%	41,500 $2.02 Million
Q2 2021 Aug 06, 2021	BUY	$25.96 - $33.44 $976,096 - $1.26 Million	37,600 New	37,600 $1.06 Million

Others Institutions Holding HRMY

# of Institutions

242

Shares Held

45.1M

Call Options Held

108K

Put Options Held

49.2K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.02B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Harmony Biosciences Holdings, Inc. Transaction History